To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05389462
Title A Study of Mipasetamab Uzoptirine (ADCT-601) in Participants with Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors ADC Therapeutics S.A.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | FRA | ESP

Facility Status City State Zip Country Details
Sarcoma Oncology Research Center Santa Monica California 90403 United States Details
Stanford Cancer Center, Stanford Medicine at Stanford University Stanford California 94305 United States Details
University of IOWA Iowa city Iowa 52242 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Sarah Cannon at University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 78229 United States Details
Vanderbilt University Medical Center (VUMC) - Ingram Cancer Center Nashville Tennessee 37232 United States Details
Institut Bergonié Bordeaux Gironde 33076 France Details
Institut Léon Bérard Lyon 69008 France Details
Centre Antoine Lacassagne Nice 06189 France Details
Hospital Universitario Vall d'Hebron Barcelona 08035 Spain Details
Hospital Universitario Fundacion Jimenez Diaz Madrid 28040 Spain Details
Hospital Universitario Madrid Sanchinarro Madrid 28050 Spain Details
The Royal Marsden NHS Foundation Trust London England SW3 6JJ United Kingdom Details
The Christie NHS Foundation Trust Manchester England M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field